Form D · Other
Andira Medicine Inc.
North Vancouver, A1 · CIK 0001916630
Offering snapshot reported Oct 9, 2026 · SEC filing
- Reported sold
- $120K Offering amount: $120K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 24, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 9, 2026 | Initial | $120,000 | No comparison | 1 | SEC filing |
| Sep 4, 2026 | Amendment | $809,922 | $0vs Sep 6, 2024 | 5 | SEC filing |
| Aug 18, 2026 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Mar 12, 2026 | Initial | $152,390 | No comparison | 3 | SEC filing |
| Sep 5, 2025 | Amendment | $809,922 | No comparison | 5 | SEC filing |
| Sep 6, 2024 | Initial | $809,922 | No comparison | 5 | SEC filing |
| Jul 10, 2024 | Initial | $18,281 | No comparison | 1 | SEC filing |
| Oct 13, 2023 | Initial | $212,008 | No comparison | 2 | SEC filing |
| Mar 15, 2022 | Initial | $393,084 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $7.2K
- Finders' fees
- $0
- Form D file number
- 021-600682
Plus 3% five-year common share warrants
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| North Point Mergers and Acquisitions, Inc. | 000133300 |
Source: Form D, filed Oct 9, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dana Lambert | Director, Executive |
| Janette Lyons | Executive |
| Evelina Rubinchik | Executive |
| Ethan Russo | Director, Executive |
| Ammad Shorbaji | Executive |
| Michael Stuart Wall | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
507 725 Marine Drive
North Vancouver, A1, V7M 0G2
North Vancouver, A1, V7M 0G2